Louise J. Bordeleau

Hamilton, ON L8S4L8, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.

Assessment of Risks and Outcomes of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Stem Cell Transplant Recipients Including Potentially Undiagnosed Cases-A Multicenter Canadian Study.

Journal: Current oncology (Toronto, Ont.)

Published: March 01, 2026

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 28, 2026

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1.

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1.

Journal: Current oncology (Toronto, Ont.)

Published: October 20, 2025

Endometriosis in Carriers of a Pathogenic Variant in BRCA1 or BRCA2: A Descriptive Analysis of a Large Multicentral BRCA Carrier Cohort.

Endometriosis in Carriers of a Pathogenic Variant in BRCA1 or BRCA2: A Descriptive Analysis of a Large Multicentral BRCA Carrier Cohort.

Journal: Current oncology (Toronto, Ont.)

Published: October 20, 2025

Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2.

Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2.

Journal: Journal of the National Cancer Institute

Published: July 16, 2025

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.

Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant.

Journal: Gynecologic oncology

Published: July 07, 2025

Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study.

Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study.

Journal: BMC cancer

Published: May 16, 2025

Implementing exercise and self-management for women with breast cancer during treatment: results of the NEXT-BRCA randomized controlled trial.

Implementing exercise and self-management for women with breast cancer during treatment: results of the NEXT-BRCA randomized controlled trial.

Journal: Scientific reports

Published: May 13, 2025

Bilateral oophorectomy and the probability of amnestic mild cognitive impairment among carriers of a pathogenic variant in BRCA1 or BRCA2.

Bilateral oophorectomy and the probability of amnestic mild cognitive impairment among carriers of a pathogenic variant in BRCA1 or BRCA2.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 20, 2025

Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant.

Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant.

Journal: British journal of cancer

Published: July 31, 2024

Incidence of endometrial cancer in BRCA mutation carriers.

Incidence of endometrial cancer in BRCA mutation carriers.

Journal: Gynecologic oncology

Published: May 15, 2024

The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation.

The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation.

Journal: Cancer

Published: May 06, 2024

Showing 1-12 of 75

Last Updated: 09/26/2026